Delivery Order SPE2DX22D0010-SPE2D826FBP28
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $137,671.25 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply provision. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor and sole...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,157.17 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,502.62 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with completion expected by December 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The order is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,648.42 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products to support federal medical procurement needs. The contract is performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,865.12 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,469.56 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $121,335.06 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under the company's existing indefinite delivery contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23,759.66 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products to support federal healthcare operations. The award is performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $141,513 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBP28Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $108,637.53 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 6, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The underlying contract structure supports the Pharmaceutical Prime Vendor Global Program, which is anticipated to eventually involve multiple regional awards across different contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $108.6k | 12/5/25 |